protein sequencing
Quantum-Si, Idex Health & Science Partner on Optics Development for Proteomics Platform
Idex, a developer of optics, fluidics, and microfluidics for the life sciences, will develop and manufacture the optical detection module for the Proteus system.
Illumina Launches Pilot Proteomics Study With UK Biobank, Inks Partnership With Nvidia
In collaboration with UK Biobank and pharma partners, Illumina will analyze 50,000 samples using the upcoming Protein Prep assay and NovaSeq X Plus platform.
Quantum-Si Prices $50M Registered Direct Offering of Common Stock
The protein sequencing firm is selling 15,625,000 shares of common stock at $3.20 per share to certain institutional investors.
While technology advances were perhaps less dramatic than in the year prior, several firms teased future releases that could have significant impacts.
The firm claims the system, called Proteus, will ultimately enable the analysis of billions of peptides, though the initial version, slated for 2026, will cover around 50 million.